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The exploration of copy-number variation (CNV), notably of somatic cells, is an understudied aspect of genome biology. Any differences
in the genetic makeup between twins derived from the same zygote represent an irrefutable example of somatic mosaicism. We studied
19 pairs of monozygotic twins with either concordant or discordant phenotype by using two platforms for genome-wide CNV analyses
and showed that CNVs exist within pairs in both groups. These ﬁndings have an impact on our views of genotypic and phenotypic di-
versity in monozygotic twins and suggest that CNV analysis in phenotypically discordant monozygotic twins may provide a powerful
tool for identifying disease-predisposition loci. Our results also imply that caution should be exercised when interpreting disease
causality of de novo CNVs found in patients based on analysis of a single tissue in routine disease-related DNA diagnostics.Monozygotic (MZ) twins represent an important resource
in genetic studies related to normal development and dis-
ease. Numerous twin registries exist,1 often specializing in
collection of phenotypically discordant MZ twins. Conse-
quently, twin research has become a powerful tool for
studying various diseases and endophenotypes, evaluating
quantitative-trait loci, estimating heritability, studying
differences in gene expression, and testing hypotheses
regarding gene-environment interactions.1 It is generally
presumed that MZ twins are genetically identical and
that phenotypic differences between twins are mainly
due to environmental factors. Examples of genetic and,
more recently, epigenetic differences between MZ twins
have, however, been described.2–5 The former are mainly
related to aneuploidies. Somatic mosaicism is usually de-
ﬁned by the presence of genetically distinct populations
of somatic cells in a single organism. Any genetic differ-
ence between MZ twins represents an extreme example
of somatic mosaicism. Earlier reports have shown somatic
mosaicism for mutations in speciﬁc disease-related genes
or chromosomal aberrations that are connected with a dis-
ease and can, for instance, result in amilder disease pheno-
type.6–9 This steadily growing body of data indicates that
somatic mosaicism for pathogenic mutations affecting
known disease genes might be seen as a rule rather than
as an exception. In addition, it was recently demonstrated
that the frequency of inversions is altered between differ-
ent populations of normal somatic cells in a healthy sub-ject.10 However, the frequency of in vivo somatic mosai-
cism for copy-number variations (CNVs) in populations
of apparently normal cells is so far unexplored.
A recent and important development in human genetics
is thediscovery of substantial large-scale structural variation
(SV) changing the chromosomal architecture (such as dele-
tions, duplications, insertions, inversions, and more com-
plex rearrangements) and occurring both in phenotypically
normal and in diseased subjects. Themost explored subtype
of SV involves changes affecting copy number of DNA seg-
ments (denotedhere asCopy-NumberVariation, [CNV]), of-
ten involving fragments of chromosomes that are consider-
able in size. Although approximately three years have
passed since the initial reports,11,12 current publications still
suggest that CNV is an underestimated aspect of the human
genome in health and disease.13 In one comprehensive re-
cent study,14 it has been suggested that the total amount
of sequence variation involving CNVs between two normal
subjects is actually higher than that for single-nucleotide
polymorphisms (SNPs).This conclusionhasbeen reinforced
by the recent increase in resolution of CNVdiscovery.15 The
advent ofmassively parallel sequencingwill soonbridge the
remaining gap between efﬁcient global analysis of SNPs and
assessments of SVs, so that in the next few years we will be
able to fully explore the ‘‘SV plasticity’’ of our genome and
its relation to normal and pathogenic variation.
The rationale of this study was to test whether pheno-
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Figure 1. Copy-Number Variation (CNV) Analysis of Twin Pair 291/292
We applied 32K BAC array (A, D, F, and G), Illumina HumanHap 300 Duo beadchip (B, C, and E), and high-resolution array based on repeat-
free nonredundant PCR fragments (H and I).
(A) and (D) illustrate combined array-CGH profiles of chromosomes 11 and 4, respectively, which were derived from two dye-swap exper-
iments on 32K BAC array for twin 292 versus 291. Relative fluorescent intensity was plotted as a straight ratio. The data points shown were
scored in both experiments and do not deviate more than one global standard deviation (SD) from each other. The global mean and one
standard deviation for these two combined experiments are 1.003 and 0.039, respectively. Two large aberrations on chromosomes 11
(~22 Mb) and 4 (~85 Mb), present in a minority of blood cells from twin 292, are highlighted by white areas. The red line shows the moving
average with a period of 30 data points.
(B) shows the values of SNP allele frequencies, obtained by the Illumina beadchip, in twin 292 on chromosome 11. The region correspond-
ing to the 22 Mb deletion is highlighted in the white box. Heterozygous SNPs are distributed around a value of 0.5.
(C) and (E) plot the values of absolute difference (Abs. Diff.) between the heterozygous SNP allele frequencies in twin 292 versus 291, as
measured by the Illumina beadchip for chromosomes 11 and 4, respectively. The solid and the dotted orange lines represent the average
and the standard deviation of the absolute difference, respectively. The larger the absolute difference between the allele frequencies in
two tested individuals, the larger the variance in copy number. The red line shows the moving average with a period of 30 data points. The
data from (A), (C), (D), and (E) were used to compute the statistical significance of the observed aberrations (Figure 4).
(F) displays the relative fraction of BACs per chromosome that deviate more than two SDs from the mean, point in the same direction (i.e.,
show deletion or gain), and are located less than 1 Mb from each other. The two combined 32K array experiments used for these calcu-
lations are displayed in (A) and (D). A higher relative score was indicative of a larger region of deviation for the particular chromosome, as
seen for chromosomes 11 and 4. Although the 11q deletion was approximately four times smaller than the deletion on chromosome 4, it
was present in a higher number of cells and thus contains higher number of BACs deviating by more than 2 SDs.
(G) displays the summary of five 32K array experiments between each of twins 291 and 292 against healthy female control (F1), displaying
155 clones within the 100–127 Mb interval of 11q. The blue dots represent the average intensity ratios of data points scored in at least
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selected MZ twins discordant for a neurodegenerative phe-
notype, display CNVs. We used two different genome-wide
platforms—the 32K BAC array and the Illumina Human-
Hap 300 Duo beadchip system—for cross-validation of
the most salient ﬁndings. We present evidence for large-
scale CNVs among MZ twins and suggest that these varia-
tions may be common, notably in somatic development.
Our results question the long-standing notion that MZ
twins are essentially genetically identical and open up
new possibilities in the use of discordantMZ twins for iden-
tifying regions harboring disease- or trait-inﬂuencing loci.
Arrays constructed with genomic clones are widely used
as a tool for CNV detection.14,16–18 The 32K BAC-array
platform is a sensitive system to assess subtle imbalances
and has been validated by use of a large number of samples
with known genotypes. The samples used in this study
were hybridized to the 32K BAC array and washed and
scanned according to previously published protocols.19
All hybridizations were done in duplicate, with the dyes
being swapped between the twins in the second hybridiza-
tion to eliminate a possible dye-speciﬁc bias. The results
were deposited in and analyzed with the Linnaeus Centre
for Bioinformatics (LCB) environment for microarray-
data management.20 Here, nonoptimal array features
were ﬁltered out, and spatial artifacts were addressed
with the use of print-tip loess normalization.19 Compara-
tive analysis was done in Microsoft Excel. Here, we ex-
cluded all clones that were not reliably scored in both hy-
bridizations for each twin. We then calculated the global
standard deviation (SD) of the remaining clones. Clones
with an internal SD larger than the global SD were ex-
cluded for further analysis. Finally, we performed a t test
to test whether the clones from the two duplicated exper-
iments deviated signiﬁcantly from the value of one, which
is the theoretical value for a normal copy-number ratio.
Computational analysis of statistical signiﬁcance was car-
ried out with the R statistical computing environment.21
We further applied the SNP-based Illumina HumanHap
300 Duo beadchip, which can also be used for copy-
number analysis.22 The Illumina hybridizations were per-
formed at the Leiden Genome Technology Center accord-
ing to the manufacturer’s instructions (Illumina, San
Diego, CA). Image analysis was performed in Illumina’s
BeadStudio software, and the raw data were exported
into Microsoft Access. Here, we ﬁltered out all data that
had allele frequency values representing homozygousSNPs. The absolute difference of the remaining heterozy-
gous SNPs between the twins in each twin pair was then
calculated and plotted. The data were ﬁnally deposited at
the GEO main page at NCBI under the accession number
GSE9609.
We studied a total of 19 pairs of MZ twins by using pe-
ripheral-blood-derived DNA (Table S1, available online).
Nine MZ twin pairs were previously collected and assessed
for Parkinson disease (PD [MIM 168600]), parkinsonism
[MIM 168600], or Lewy body dementia [MIM 127750] by
the Swedish Twin Registry (STR).23,24 Six of these nine
MZ twin pairs were discordant for probable or possible
PD, two pairs were discordant for parkinsonism of un-
known cause, and one pair was discordant for Lewy body
dementia. In two of the six MZ twin pairs discordant for
PD, the co-twin had essential tremor, and in one pair, the
co-twin had a mixed form of parkinsonism (Table S1).
Ten phenotypically unselected and concordant normal
Dutch MZ twins were collected as part of the Netherlands
Twin Register (NTR).25 The monozygosity of the STR twins
was determined on the basis of questionnaires, which alone
have a 98% probability of correct zygosity establishment,23
and was further conﬁrmed by genotyping with 13–18 SNPs
distributed throughout the genome. On the basis of allele
frequencies from 249 control subjects,26 the probability of
being concordant at that number of unlinked loci, assum-
ing dizygosity, was less than 0.03 (Table S1 and data not
shown). The ten NTR MZ twins were genotyped on the
SNP beadchip containing more than 300,000 SNPs, and
genotypes were concordant for all SNPs.
The primary platform for analysis of STR twin pairs was
the 32K BAC array. We compared one twin versus its co-
twin and each twin against a genetically well-characterized
normal female control (F1).19 The latter comparison serves
to assess the true genotype of the twins (i.e., presence of
putative shared CNV), whereas the former experiments
show putative imbalance within each twin pair. BAC-array
proﬁles from experiments between any twin versus F1 are
consistently noisier, with higher standard deviations, com-
pared to experiments using DNA from one twin versus
another from the same pair (not shown). Comparisons
within the STR twin pairs revealed a considerable number
of loci suggestive of putative CNV. For instance, the proﬁle
from twin pair 291/292 points to a deletion encompassing
22 Mb of 11q in subject 292 on the basis of proﬁles from
seven experiments (Figure 1). This ﬁnding was conﬁrmedtwo 292-versus-F1 hybridizations. Red dots show the average value of two 291-versus-F1 experiments. The mean and SD shown were
calculated with data points from the 102–124 Mb interval for the respective hybridizations. These experiments show that the CNV
detected on 11q represents a deletion in twin 292.
(H) Array-CGH analysis of DNA from twin 292 versus 291 on the confirmatory PCR-based array covering the four shaded clones. The mean
and SD for the six chromosome 11 data points are 0.899 and 0.022, respectively. Corresponding numbers for the nonchromosome 11 data
points are 1.006 and 0.018.
(I) Summary of two array-CGH hybridizations of twin 291 against F1 (red) and twin 292 against F1 (blue) on the same array shown in (E).
The average intensity ratio for autosomal PCR fragments for twin 291 is 1.000, SD ¼ 0.031. The average intensity ratio for nonchromo-
some 11 autosomal fragments for twin 292 is 1.011, SD ¼ 0.021. The average ratio for the chromosome 11 clones for 292 is 0.907,
SD ¼ 0.039.
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and reﬁned on the Illumina beadchip (Figure 1). The cen-
tromeric breakpoint of the 22 Mb deletion, located at
~102 Mb, overlaps with a known intrachromosomal seg-
mental duplication, and this deletion encompasses the
ATM gene [MIM 607585] (see below). Comparing the
BAC-array ratios with experiments in which all cells are af-
fected by an imbalance (e.g., ratios for chromosome X in
hybridization of male versus female), we estimated that
the deletion in twin 292 is present in ~20% of nucleated
blood cells.16 We also conﬁrmed this CNV in quintuple
in a high-resolution, repeat-free, nonredundant, PCR-
based array (Figure 1), a test we previously developed for
the detection of pathogenic gains and deletions and the
discovery of CNV.27–29 Details regarding this conﬁrmatory
array are available from the authors upon request.
In addition to the 11q rearrangement, another large
deletion, affecting 4p and a considerable part of 4q, was
found in twin 292 by both 32K BAC analysis and Illumina
beadchip (Figure 1). This ~85 Mb deletion was present in
~10–15% of cells. On the basis of the striking conjunction
of two very large deletions, we searched the literature and
found that chromosome 4 deletion and an 11q deletion,
which targets the ATM gene, are common for chronic lym-
phocytic leukemia (CLL [MIM 151400]).30,31 We were not
previously aware of any additional disease affecting twin
292, but consultation of the medical records conﬁrmed
that subject 292 had been diagnosed with CLL prior to
sampling of his blood in the course of our study (Table
S1). We have thus ‘‘rediagnosed’’ a clone of CLL cells con-
taining two somatic and pathogenic CNVs in this twin. In
this case, because we are studying the correct target tissue,
we are conﬁdent that these two changes are truly patho-
genic. The fact that we were able to detect this, in spite
of a low percentage of cells containing aberrations, is
a good illustration of the power of both genome-wide array
platforms. As far as we are aware, the chromosome 4 aber-
ration in subject 292 represents the lowest reported num-
ber of cells containing a change that has been detected
via an array-based genome-wide platform for CNV screen-
ing. There are two main challenges in scoring ‘‘somatic
CNVs’’ in monozygotic twins or other types of samples
used for analysis of somatic mosaicism for copy-number
changes. One concern is usually the small size of these
CNVs. The second is that these aberrations will typically
occur in only a proportion of cells. Both of these aspects
make the analysis more challenging than scoring ‘‘germ-
line CNVs’’ that are expected to be present in 100% of stud-
ied cells. The other eight STR MZ pairs also showed addi-
tional imbalances on the 32K BAC array, and this was
replicated on the Illumina beadchip for two pairs. For in-
stance, Figure 2 displays ﬁve small deviating loci, concor-
dant between 32K array and Illumina, in twin pairs 491/
492 and 701/702.
Several other putative CNV loci were found with the 32K
arrays in six additional STRMZ pairs (Figures S1A and S1B).
These loci were deﬁned by two dye-swap experiments with
at least two overlapping BAC clones deviating by>2 global766 The American Journal of Human Genetics 82, 763–771, Marchstandard deviations, the same criteria used when scoring
the 11 Mb and 85 Mb deletions in twin 292. Tables S2–S4
further summarize the deviating loci, deﬁned as single
BACs or neighboring/overlapping BACs in all STR-twins
with different cutoffs of statistical signiﬁcance (difference
ofR2 orR3 global SDs). There were 31 loci that deviated
in three phenotypically discordant MZ pairs and four loci
that deviated in four such pairs (Tables S3 and S4). These
can be viewed as candidates for containment of genes
involved in the development of PD.
For the analysis of the ten phenotypically concordant
twin pairs from NTR, the Illumina system was the primary
platform used (Table S1). In addition to the concordant
SNP genotypes (see above), including several CNVs that
were shared by both twins of a pair, a few discordances
in A and B allele frequencies were also found, suggesting
putative de novo somatic CNV events. Figure 3 shows
a clear example of a large CNV, which covers ~1.6 Mb on
chromosome 2 in twin pair D and extends from SNPs
rs2304429 to rs1662987, implying a deletion in twin D8.
On the basis of the quantiﬁcation, it too is found to be
present in less than 100% of the cells. Two additional
methods were applied to validate this ﬁnding: high-resolu-
tion Melting Curve Analysis and pyrosequencing (Figures
3C and 3D). Both methods conﬁrmed the presence of the
deletion and indicated that it was present in approxi-
mately 70–80% of blood cells from D8. Circumstantial
evidence was obtained for other, posttwinning CNVs, but
the statistics of identifying somatically mosaic (i.e., incom-
plete) CNVs by SNP concordance analysis requires further
methodological development beyond the scope of this
report.
Analysis ofCNVs is a generally understudied aspect ofhu-
man genetic variation, particularly in somatic cells. MZ
twins represent an excellent focus for such studies because
any genotypic difference between twins derived from the
same zygote highlights an irrefutable case of somatic varia-
tion. It is likely that the conﬁrmed CNVs shown here repre-
sent only the ‘‘tip of an iceberg’’ of all CNVs that are actually
present in the studied twins. The notion of somatic varia-
tion being far more common than previously assumed
agrees well with our other, recent results showing CNVs be-
tweennormal, fullydifferentiated tissueswithin an individ-
ual human subject (A.P., C.E.G.B., R.A., T.D.d.S., U.M., J.S.,
D.v.T., A.P., C.C., E.C.P., J.K., and J.P.D., unpublished data).
Our ﬁndings inﬂuence the understanding of phenotypic
and genotypic diversity inMZ twins. First, we wish to stress
that although our data seem to suggest a difference, it is
not justiﬁed to conclude that phenotypically discordant
MZ twins are more frequently affected by CNV than are
concordant MZ twins. To assess this question, larger co-
horts of both twin categories need to be analyzed, prefera-
bly by use of DNA extracted from multiple tissues. On the
other hand, some of the CNVs in twins discordant for
Parkinson disease, parkinsonism, or Lewy body dementia
might be pathogenic for these phenotypes, especially
when they would also be present in the affected cells of2008
the central nervous system. Indeed, a frequent limitation
of CNV analyses as generally performed in the context of
somatic disorders is that the genotype of one tissue ana-
lyzed (usually blood) might not always be relevant to the
genotype of the tissue responsible for the disease, a phe-
nomenon well known for other disorders.32 Second, our
ﬁndings issue a note of caution. Because genome-wide
tools show de novo CNVs in healthy individuals, we
Figure 2. Parallel CNV Analysis with Two CNV Platforms
We show five loci deviating in twin pairs 701/702 and 491/492 on the 32K BAC array (A, C, E, G, and I) and the Illumina HumanHap 300
Duo beadchip (B, D, F, H, and J). Regions altered between the two twins in each pair were defined as having at least two overlapping BAC
clones that differ by R2 global standard deviations and are supported by at least one corresponding and one deviating SNP on the
Illumina beadchip.
32K BAC array-CGH profiles were derived from two dye-swap experiments. Relative fluorescent intensity was plotted as a straight ratio. The
data points shown were scored in both experiments and were not deviating more than one global SD from each other. The global mean and
one SD for these two combined experiments were 1.003 and 0.039, respectively. The horizontal blue lines represent the average straight
ratio, and error bars for each BAC show SD between two measurements in dye-swap experiments.
(B), (D), (F), (H), and (J) show the absolute difference in allele frequencies for the heterozygous SNPs on the beadchip for the corre-
sponding chromosomal regions. The solid orange lines indicate the average absolute difference for all heterozygous SNPs for each of
the twin pairs, and the dotted lines indicate the standard deviation (SD) for these. The green diamonds indicate SNPs deviating from
the average with more than one SD. All genomic positions on the x axis are in million base pairs (Mb) and according to the hg18 build.
The American Journal of Human Genetics 82, 763–771, March 2008 767
Figure 3. CNV Analysis of Twin D8
Showing the 1.6 Mb Deletion on Chromo-
some 2
(A) Profile of the entire chromosome 2 from
Illumina HumanHap 300 Duo beadchip
showing the values of SNP allele ratios.
True heterozygous SNPs are expected to
be distributed around a value of 0.5. In
the highlighted region (white box), the
allele ratios differ significantly from 0.5,
indicating an imbalance in the allele
signals caused by a 1.6 Mb deletion.
(B) Two enlarged views of the deleted re-
gion, plotted as values of absolute differ-
ence between the heterozygous SNP allele
frequencies in twin D8 versus twin D7, cal-
culated in a similar way as shown in Figures
1C and 1E. The red line in both graphs dis-
plays the moving average, with a period of
30 and five data points in the left- and
right-hand graphs, respectively. The solid
and the dotted orange lines represent
the average and the standard deviation
of the absolute difference, respectively.
The green arrows indicate the SNP
rs11674089, used for confirmatory experi-
ments using Melting Curve Analysis (C)
and pyrosequencing (D).
To confirm the presence of the deletion and
to estimate the number of cells carrying
it, we performed high-resolution Melting
Curve Analysis (hrMCA, [C]) and pyrose-
quencing (D). For hrMCA, reference sam-
ples were made from homozygous AA and
BB individuals and mixes of AA:BB of 1:1,
3:1 and 1:3. MCA shows the signals for
the homozygous AA and BB samples as
nearly identical, whereas the signal of
twin D7 (heterozygous for this SNP)
matches that of the reference AB sample.
The signal for twin D8 does not follow
that of the reference AB sample but follows that of the AA:BB 3:1 sample instead, confirming the deletion and estimating it as being
present in 70%–80% of the cells.
(D) displays pyrosequencing analysis of the SNP rs11674089 for twins D7 (left panel) and D8 (right panel). Taking the G to A ratio of twin
D7 as normal (50:50), the G to A ratio in twin D8 shifts to 3:1, suggesting that ~70%–80% of the cells analyzed carry the 1.6 Mb deletion.should expect such changes when analyzing patients. The
detection of de novo aberrations has so far been considered
evidence for a causal link between mutation and disease
status of a patient. We show that one should be careful
when drawing such conclusions.
Finally, estimating the frequency with which de novo
CNVs occur is currently difﬁcult. On the basis of the de-
tection of one megabase-range, conﬁrmed CNV among
ten unselected, phenotypically concordant MZ twin pairs
next to several potential ones with a lower degree of cellu-
lar mosaicism and/or smaller size, the de novo posttwin-
ning CNV frequency could be as high as 5% on a per-indi-
vidual basis or 10% per twinning event. The detection rate
among the discordant Parkinson twins suggests an even
higher ﬁgure, but this is within a selected, discordant768 The American Journal of Human Genetics 82, 763–771, Marchgroup and thus might represent a mixture of phenotypi-
cally relevant, as well as random, and phenotypically
neutral CNV events. This ﬁgure is clearly only a ﬁrst ap-
proximation, and a larger cohort of MZ twins needs to be
studied in order to more accurately deﬁne the frequency.
It is not straightforward to derive supporting evidence
from other studies, because parents were typically not an-
alyzed in these studies. One such estimate, based on the de
novo deletion frequency in the DMD gene [MIM 300377],
which lacks conspicuous low-copy repeats (segmental
duplications) enhancing propensity for rearrangements,
arrives at one de novo deletion per eight newborns and
one duplication per 50 newborns.33 Sebat et al.34 mention
the detection of one de novo deletion when 28 CEPH indi-
viduals were studied, an essentially similar frequency. We2008
Figure 4. Statistical Analysis of Two Dye-Swap Experiments from Twin 291 versus 292
(A) Dye-swap-averaged log2 ratios of the data points from the long arm of chromosome 11 (11q) between twins 291 and 292. Boundaries
of the inferred region of deletion are marked. A nonparametric Wilcoxon rank sum test comparing the values of the 120 data points within
the region to the 359 data points outside the region yields a p value less than 2.2 3 1016. In a series of n points, the number of con-
tiguous regions of any length was n(n-1)/2, because a contiguous region was defined by its boundaries. The number of possible regions in
the data shown in (A) was therefore 114,481. Thus, even the Bonferroni-corrected p value was on the order of 1011. This shows that the
region of deletion was not merely the result of capitalizing on chance.
(B), (C), and (D) display the autocorrelation function (ACF) computed on the data shown in (A). (B) was computed with all data points
from 11q, and (C) and (D) were computed on data points within and outside the deleted region, respectively. The ACFs show that the
autocorrelation evident in (B) was due almost entirely to the deletion and was negligible after controlling for it.note that the frequency of de novo CNVs strongly depends
on the cutoff criteria set to detect these, especially when
the size of an aberration and the number of cells affected
by it diminish. In the above circumstances, the conﬁrma-
tion of CNVs via alternative techniques becomes particu-
larly challenging. Our work clearly suggests a need for
new, better methods for conﬁrmatory analyses, of which
massively parallel sequencing seems promising.15 On the
other hand, our results also point to the feasibility of stud-
ies targeting larger cohorts of MZ twins discordant for var-The Aious phenotypes as a way to characterize genetic factors
predisposing one to disease. Future studies should ideally
be performed with the use of DNA extracted from more
than one tissue, or from cells derived from the same devel-
opmental lineage as the target tissue that is responsible for
generation of the discordant phenotype.
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